Product Information

CARBIDOPA-LEVO 25-100 MG ODT is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.6971 per EA under NDC 16571015801. Its NADAC has been published 30 times since Jan 28, 2026.

FDA first approved this application on Sep 18, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the carbidopa and levodopa market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for CARBIDOPA-LEVO 25-100 MG ODT has been published 30 times since Jan 28, 2026, and over the history we have for it it has declined 8.4%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 90% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.